Evidence map›Paper›PMID 32854106›Full record

GuidelineRespiration; international review of thoracic diseases2020

Sleep Breathing Disorders in the COVID-19 Era: Italian Thoracic Society Organizational Models for a Correct Approach to Diagnosis and Treatment.

Giuseppe Insalaco, Fabrizio Dal Farra, Alberto Braghiroli, Sacco, Adriana Salvaggio, on behalf of the Italian Thoracic Society (ITS-AIPO)

Open access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Respiration; international review of thoracic diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Impact of the COVID-19 pandemic on positive airway pressure adherence and patients' perspectives in Greece: the role of telemedicine.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  2. Disrupted Sleep During a Pandemic.Sleep medicine clinics · 2022
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Giuseppe InsalacoInstitute for Biomedical Research and Innovation, National Research Council of Italy, Palermo, Italy, giuseppe.insalaco@irib.cnr.it.
Fabrizio Dal FarraRespiratory Unit, ULSS 7 Pedemontana, Bassano del Grappa, Italy.
Alberto BraghiroliSleep Laboratory, Department of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Veruno, Italy.
SaccoSleep Laboratory, Department of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Veruno, Italy.
Adriana SalvaggioInstitute for Biomedical Research and Innovation, National Research Council of Italy, Palermo, Italy.
on behalf of the Italian Thoracic Society (ITS-AIPO)
National Research Council · ITInstitute for Biomedical Research and Innovation · ITIstituti Clinici Scientifici Maugeri · ITOspedale San Bassiano · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The attenuation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, at least in Italy, allows a gradual resumption of diagnostic and therapeutic activities for sleep respiratory disorders. The knowledge on this new disorder is growing fast, but our experience is still limited and when a physician cannot rely on evidence-based medicine, the experience of his peers can support the decision-making and operational process of reopening sleep laboratories. The aim of this paper is to focus on the safety of patients and operators accessing hospitals and the practice of diagnosing and treating sleep-related respiratory disorders. The whole process requires a careful plan, starting with a triage preceding the access to the facility, to minimize the risk of infection. Preparation of the medical record can be performed through standard questionnaires administered over the phone or by e-mail, including an assessment of the COVID-19 risk. The home sleep test should include single-patient sensors or easy-to-sanitize material. The use of nasal cannulas is discouraged in view of the risk of the virus colonizing the internal reading chamber, since no filter has been tested and certified to be used extensively for coronavirus due to its small size. The adaptation to positive airway pressure (PAP) treatment can also be performed mainly using telemedicine procedures. In the adaptation session, the mask should be new or correctly sanitized and the PAP device, without a humidifier, should be protected by an antibacterial/antiviral filter, then sanitized and reassigned after at least 4 days since SARS-CoV-2 was detected on some surfaces up to 72 h after. Identification of pressure should preferably be performed by telemedicine. The patient should be informed of the risk of spreading the disease in the family environment through droplets and how to reduce this risk. The follow-up phase can again be performed mainly by telemedicine both for problem solving and the collection of data. Public access to hospital should be minimized and granted to patients only. Constant monitoring of institutional communications will help in implementing the necessary recommendations.

Indexed as

Coronavirus InfectionsPandemicsPneumonia, ViralAir FiltersBetacoronavirusClinical Decision-MakingContinuous Positive Airway PressureCOVID-19Disease ManagementDisinfectionEvidence-Based MedicineHumansItalyPolysomnographyPulmonary MedicineSARS-CoV-2PolysomnographySevere acute respiratory syndrome coronavirus 2Sleep medicineSleep-related respiratory disordersTelemedicine

Identifiers

PMID32854106
PMCPMC7490486
OpenAlexW3080870829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.